Sign in to follow
Search Results

0 results for 'Berger Montague'

You can use to get even better search results
November 23, 2009 |

PaLAW 2009 Top 100 Firms

22 minute read
November 08, 2012 |

The Big Money Behind Warren and Brown's Mass. Senate Race

An analysis by MapLight.org of campaign finance data from the Federal Election Commission traced the sources behind the more than $50 million raised by Elizabeth Warren and Senator Scott Brown in their race for a senate seat in Massachusetts.
3 minute read
September 24, 2002 |

Judge OKs Cell Pathways Settlement

A federal judge has approved the settlement of a class-action shareholder`s suit against Cell Pathways Inc. of Horsham in which the pharmaceuticals company will pay the plaintiffs $2 million in cash and 1.7 million shares of CPI common stock.
3 minute read
August 12, 1999 |

Despite Reform, Shareholder Suits Still Big in Philly

Securities-fraud litigators in Philadelphia are as busy as ever despite legislation designed to make it more difficult to accuse public companies of dishonesty. The constant level of activity reflects national figures showing that the number of stock-fraud lawsuits reached a record high last year. Class-action lawyers say that instead of slowing the pace, the 1995 law has caused plaintiffs to become more selective while allowing defendants to prevent more cases from proceeding past the filing stage.
5 minute read
November 23, 2009 |

Total Attorneys Worldwide

11 minute read
June 08, 1999 |

Cephalon Settles Shareholder Suits For $17 Million in Cash and Stock

Cephalon Inc. has agreed to pay $17 million to settle a spate of class-action shareholder suits filed in 1996 that said top corporate officers hid the truth about the prospects of an experimental drug to treat Lou Gehrig's disease. Senior U.S. District Judge Clifford Scott Green yesterday granted preliminary approval of the settlement, clearing the way for notices of it to be published in the Wall Street Journal and mailed to potential class members.
4 minute read
In Major Pay-to-Delay Momentum Shift, Pennsylvania Judge Green-Lights Antitrust Class Actions and FTC Claims Against Cephalon and Generics
Publication Date: 2010-03-30
Practice Area:
Industry:
Court:
Judge:
Attorneys:
For plaintiff:
For defendant:
Case number:

This could be a game changer, folks--and it couldn't come at a more critical moment for opponents of the deals that keep generic drugs off the market.

May 03, 2000 |

The Ever-Changing World of Lateral Hires

7 minute read
Billion-Dollar Judgment Is Bad Omen for J&J As States Take on Drug Marketing
Publication Date: 2012-04-16
Practice Area:
Industry:
Court:
Judge:
Attorneys:
For plaintiff:
For defendant:
Case number:

Last week's $1.1 billion award against Johnson & Johnson's Janssen Pharmaceuticals unit was the biggest yet in a cascade of state court judgments over marketing of the anti-psychotic Risperdal. But it's not over yet: More state AGs are now jumping into the fray, and J&J's lawyers at Drinker Biddle haven't shown any inclination to settle.

TRENDING STORIES

    More from ALM

    More from ALM

    Legal Speak is a weekly podcast that makes sense of what’s happening in the legal industry.

    Resources